Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. - Wikidata - wikimedia - TriplyDB

Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement.

Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement.

http://www.wikidata.org/entity/Q27687541

about

Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections Community IntraVenous Antibiotic Study (CIVAS): protocol for an evaluation of patient preferences for and cost-effectiveness of community intravenous antibiotic services Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists Intravenous antimicrobial therapy in the hospital-at-home setting: data from the Spanish Outpatient Parenteral Antimicrobial Therapy Registry.Managing an outpatient parenteral antibiotic therapy team: challenges and solutions.Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore.Outpatient parenteral antimicrobial therapy practices among adult infectious disease physicians.The Impact of an Infectious Diseases Transition Service on the Care of Outpatients on Parenteral Antimicrobial Therapy.A prospective cohort study of the use of domiciliary intravenous antibiotics in bronchiectasis.Antimicrobial Stewardship from Policy to Practice: Experiences from UK Antimicrobial Pharmacists.Comparative outcomes of β-lactam antibiotics in outpatient parenteral antibiotic therapy: treatment success, readmissions and antibiotic switches.Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review.Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis.Are we ready for an outpatient parenteral antimicrobial therapy bundle? A critical appraisal of the evidence Outpatient parenteral antimicrobial therapy (OPAT) in the Republic of Ireland: results of a national survey.Management of suspected Lyme borreliosis: experience from an outpatient parenteral antibiotic therapy service.Good practice recommendations for paediatric outpatient parenteral antibiotic therapy (p-OPAT) in the UK: a consensus statement.Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity.Optimization of a model of out-of-hospital antibiotic therapy (OPAT) in a Belgian university hospital resulting in a proposal for national implementation.Patient Characteristics and Outcomes of Outpatient Parenteral Antimicrobial Therapy: A Retrospective Study.Patient retention of training in self-administration of intravenous antibiotic therapy in an outpatient parenteral antibiotic therapy service.Extended stability of antimicrobial agents in administration devices.Optimising patient safety when using elastomeric pumps to administer outpatient parenteral antibiotic therapy.Outpatient parenteral antimicrobial therapy.Diabetic foot infection: Antibiotic therapy and good practice recommendations.Economic evaluation of outpatient parenteral antimicrobial therapy: a systematic review.Patient satisfaction in an outpatient parenteral antimicrobial therapy (OPAT) unit practising predominantly self-administration of antibiotics with elastomeric pumps.Antibiotic stability related to temperature variations in elastomeric pumps used for outpatient parenteral antimicrobial therapy (OPAT).Outpatient parenteral antibiotic therapy (OPAT) in Asia: missing an opportunity.How is income generated by outpatient parenteral antibiotic treatment (OPAT) in the UK? Analysis of payment tariffs for cellulitis.Management of hospitalized patients with diabetic foot infections.A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT).Effectiveness and safety of outpatient parenteral antimicrobial therapy in acute exacerbation of chronic obstructive pulmonary disease.Monitoring of Outpatient Parenteral Antimicrobial Therapy and Implementation of Clinical Pharmacy Services at a Community Hospital Infusion Unit.Economic evaluation of treatment for MRSA complicated skin and soft tissue infections in Glasgow hospitals.Patterns of outpatient ceftriaxone use in a Japanese general hospital: an increased need for development of outpatient parenteral antimicrobial therapy programs.Outpatient parenteral antimicrobial therapy: its delivery in the community.Antimicrobial infusions in the community.Outpatient parenteral antimicrobial therapy.Service development of a nurse-led community-based PICC insertion service.

P2860

Q26752922-DFBAEF56-1368-455A-A535-F9579E8D17E7 Q26795673-238C7839-5699-4F06-90FB-A7946FC4CF02 Q28088622-580F418F-C6D6-4805-9E1C-A6758CAB7545 Q31058008-A271EC3F-B783-4F26-B6E9-CE8EE7E3F7C8 Q33800937-75EF8946-6EAF-49E4-82BC-9193DAB4CC23 Q33882847-A63B64D3-6A5B-4BB7-B32A-CBA009BA0C98 Q34267229-F7B148E3-D5AC-460B-AC2C-CD32F82774AC Q34993276-1B2F0E65-C6A9-4584-B8F7-CAB63396ED0F Q35216468-5906EDD3-BA15-4258-9394-6C1E448F4B1B Q36059150-D9050158-CE33-489F-BB24-793EA941641D Q36087129-E2CE2FDA-6446-4137-B982-ACC8341BA9AA Q36352808-CF6B9522-271A-48E1-97AE-A3918D028832 Q36929387-09A000D3-F8DF-4DE6-81F6-DC28B52AB2E0 Q36987584-60BACE29-1B16-4A16-863C-5CEE070EFCB8 Q37680028-B835CC76-B301-46BE-B9C8-026A1C391212 Q38052415-FFF754C7-8F9A-4BC3-8294-336A98EECD23 Q38261504-8CC7448E-F6FF-4F65-AB29-A63DA88D9C08 Q38737317-C0DAD767-F619-4126-A4F0-12BDDDCD54BA Q38839863-7454493D-A1AE-41A0-AAF3-8A850F96BBDD Q38882993-1D744C34-5701-4658-B9C5-14F13C8DE82D Q38981632-8B269DBE-2EFA-4BF0-8447-824CAC041D55 Q39028271-1A6CBF41-270D-4B31-A53B-E69EBDF89645 Q39238504-CE60FD64-586E-4A5C-87DC-290940189508 Q39938810-700167D7-4E3B-4A8A-9096-9FB6A55223B7 Q40053813-928A5A15-E7EC-40A3-AF83-3838433F5012 Q40106877-DD8F4A09-E67E-424E-887A-3CCB1EF80BAE Q40298619-95D64E8B-E27C-4152-BC7E-54681E6812D3 Q40346673-3E5B7B62-2F0E-4753-AB56-EDAD447F7D32 Q40375777-54CB7E2E-DCEC-4B0A-BBAC-C738ECAB31E4 Q41564178-6ED844ED-6D94-4CAE-A8B3-5DA08D417BC3 Q41602006-CC6355CA-675F-4C98-8503-ED180F94A2EC Q41653080-D203E623-5127-4BBB-8203-3BC5A05E6CCF Q41994102-6B26A7CE-B940-4E92-8412-C6381EF72C1D Q42202591-29195C92-BA8E-4C70-89FB-F71A6D870B9A Q42249120-9B62B0C8-3AFF-4BD9-B0A8-E5BF78BC3265 Q43464031-44086A76-9965-4A2C-8294-13689FE1C70B Q43632863-E71E443A-0C48-447C-B2D6-BDEED79AA7B7 Q45351867-DD35DE31-E204-4283-8A46-D152AAB6FB8D Q50121508-2F9B3D4F-30BD-464B-8C47-ED6E422156CE Q51025737-F4B5942D-53D0-43CD-BDA6-54BB9E1A7C63

P2860

Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement.

http://www.wikidata.org/entity/Q27687541

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Good practice recommendations ...... the UK: a consensus statement.

@ast

Good practice recommendations ...... the UK: a consensus statement.

@en

Good practice recommendations ...... the UK: a consensus statement.

@nl

type

label

Good practice recommendations ...... the UK: a consensus statement.

@ast

Good practice recommendations ...... the UK: a consensus statement.

@en

Good practice recommendations ...... the UK: a consensus statement.

@nl

prefLabel

Good practice recommendations ...... the UK: a consensus statement.

@ast

Good practice recommendations ...... the UK: a consensus statement.

@en

Good practice recommendations ...... the UK: a consensus statement.

@nl

P1433

Q27687541-225EFB6A-A8E9-4F1B-8231-8F4A21B61566

P1476

Q27687541-EF9E1844-68BA-47A6-8C3C-641B920EC69E

P2093

Q27687541-3591B9C1-26B7-4037-9A43-448644BF850A

Q27687541-423DD4DA-6C00-428E-975F-3985D984C117

Q27687541-49E3616C-571F-46CF-8A3A-A633D2C0C98F

Q27687541-6B030D9C-0859-44D7-9DB9-8B02DF11F22E

Q27687541-87C56827-B853-43EC-8C74-C5FFA499DCA3

Q27687541-8DAE2D3C-3452-4D8A-BA67-D5EB2DE9A32E

Q27687541-9697DB86-69FD-41F8-92D1-2B44664ACA7E

Q27687541-C640A8DD-D963-49CF-AB09-C701DF11DC2D

P2860

Q27687541-0442F93D-7D37-409F-98B4-8FB57224C163

Q27687541-0AE9298E-B8FF-4D03-B733-6E4BA85B2C40

Q27687541-120FF70B-FF5F-4582-B24E-1F50F5B8D3A4

Q27687541-13259B41-6530-4021-980E-6A436650B1B6

Q27687541-1AB44D46-DBDD-4A8E-AAC5-DDF93898AAF3

Q27687541-1E80DAC2-E54F-45AB-8CDD-E680208C62AB

Q27687541-2EB74911-D60E-40A6-81CE-E736EF83F4F1

Q27687541-329F7BAC-43A7-4D62-ABCB-370896D2AB3D

Q27687541-3612E9B8-5AE4-4C37-93F8-49A90F6504AE

Q27687541-38FF0B2F-48EE-4E8D-9D23-D9F5D961C86F

P304

Q27687541-FD98A843-7B7A-4995-96DD-6FCA84C54FC7

P31

Q27687541-F4132E86-E3A7-426F-BC63-41E182C5503F

P3181

Q27687541-C9415A74-FD49-4500-8A5B-09AD98F83287

P356

Q27687541-8E49DCB8-9AB2-4D66-8A18-15F7B1D16080

P407

Q27687541-0CE2384C-7322-4458-9490-9C1E6BE81969

P433

Q27687541-A01ED63F-B962-466A-843F-593CC90948F0

P478

Q27687541-7FE8A3AF-86B7-45A4-8FE8-A3D63415C047

P577

Q27687541-6058D76F-17CB-455A-A4BC-72EAF33EA613

P5875

Q27687541-E28CB52D-E199-4C08-8929-97F90709BADB

P698

Q27687541-62C0A1AF-0AD5-4C46-B21A-3F9E1D313F28

P3181

P356

P1433

Journal of Antimicrobial Chemotherapy

P1476

Good practice recommendations ...... the UK: a consensus statement.

@en

P2093

A. L. N. Chapman

http://www.w3.org/2001/XMLSchema#string

C. Reed

http://www.w3.org/2001/XMLSchema#string

D. Nathwani

http://www.w3.org/2001/XMLSchema#string

F. Sanderson

http://www.w3.org/2001/XMLSchema#string

M. A. Cooper

http://www.w3.org/2001/XMLSchema#string

R. A. Seaton

http://www.w3.org/2001/XMLSchema#string

S. Hedderwick

http://www.w3.org/2001/XMLSchema#string

V. Goodall

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro susceptibility to everninomycin of gram-positive nosocomial pathogens isolated from intensive care units in Germany.

Adverse effects of outpatient parenteral antibiotic therapy.

Disposable infusion pumps.

Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital.

Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.

Advisory group on Home-based and Outpatient Care (AdHOC): an international consensus statement on non-inpatient parenteral therapy.

Patient selection criteria and management guidelines for outpatient parenteral antibiotic therapy for native valve infective endocarditis.

Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the Eu

Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.

Medication safety in home infusion care.

P304

1053-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2278786

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/JAC/DKS003

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221799328

http://www.w3.org/2001/XMLSchema#string

P698

22298347

http://www.w3.org/2001/XMLSchema#string